HHS announced $22 billion in funding to support expanded testing, vaccination distribution
On Jan. 6, 2021, the U.S. Department of Health and Human Services (HHS) announced the Centers for Disease…
On Jan. 6, 2021, the U.S. Department of Health and Human Services (HHS) announced the Centers for Disease…
On Jan. 5, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announed that a phase 2/3…
On Jan. 5, 2021, AIM ImmunoTech announced that the active AMP-511 Expanded Access Program (EAP) had dosed its…
Greek philosopher Theophrastus (371-287 BCE), the “Father of Botany” wrote of Greeks rotating their staple crops with broad…
On Jan. 4, 2021, the FDA announced that the two different mRNA vaccines were shown remarkable effectiveness of…
On Jan. 4, 2021, Audrey Winkelsas, a 2015 NIH Oxford-Cambridge Scholars Program doctoral student with spinal muscle atrophy…
On Dec. 30, 2020, Bausch Health announced that the Office for Registration of Medicinal Products, Medical Devices and…
On Dec. 30, 2020, the COVID-19 vaccine developed by Oxford University/AstraZeneca was given regulatory approval by the UK…
On Dec. 29, 2020, Emergent BioSolutions and Mount Sinai Health System announced initiation of the clinical program to…
On Dec. 29, 2020, Regeneron announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the…
On Dec. 28, 2020, Soligenix announced that the National Institute of Allergy and Infectious Diseases (NIAID), had awarded…
On Dec. 23, 2020, Merck announced an agreement with the U.S. Government to support the development, manufacture and…
On Dec. 23, 2020, Serum Institute of India and Dynavax jointly announced that the first participants had been…
On Dec. 23, 2020, VBI Vaccines announced that the European Medicines Agency (EMA) has accepted the filing of…
On Dec. 23, 2020, Altimmune announced that the FDA had issued a clinical hold on the Companyメs Investigational…
On Dec. 23, 2020, Tonix Pharmaceuticals announced that it had completed the purchase of an approximately 44-acre site…
On Dec. 23, 2020, Pfizer and BioNTech announced a second agreement with the U.S. government to supply an…
On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…
On Dec. 22, 2020, Abivax announced that the Companyメs ongoing ABX464 phase 2b/3 trial in high-risk Covid-19 patients…
On Dec. 22, 2020, a phase II clinical trial of a treatment for COVID-19 patients was started at…
On Dec. 22, 2020, the ACIP updated interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be…
On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…
On Dec. 22, 2020, the NIH researchers announced they had isolated a set of promising, tiny antibodies, or…
On Dec. 1, 2020, the governmenrt of Singapore announced that it had given U.S. start-up Eat Just the…
On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…
On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…
On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…
On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyメs Investigational New Drug (IND)…
On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyメs Investigational New Drug (IND)…
On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpル At-Home COVID-19 Collection Kit is…